Literature DB >> 9461053

1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention.

.   

Abstract

These guidelines for the treatment of patients who have sexually transmitted diseases (STDs) were developed by CDC staff members after consultation with a group of invited experts who met in Atlanta on February 10-12, 1997. The information in this report updates the "1993 Sexually Transmitted Diseases Treatment Guidelines" (MMWR 1993;42[no. RR-14]). Included are new recommendations for treatment of primary and recurrent genital herpes and management of pelvic inflammatory disease; a new patient-applied medication for treatment of genital warts; and a revised approach to the management of victims of sexual assault. Revised sections describe the evaluation of urethritis and the diagnostic evaluation of congenital syphilis. These guidelines also include expanded sections concerning STDs among infants, children, and pregnant women and the management of patients who have asymptomatic human immunodeficiency virus infection, genital warts, and genital herpes. Guidelines are provided for vaccine-preventable STDs, including recommendations for the use of hepatitis A and hepatitis B vaccines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461053

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  72 in total

1.  Ability of the digene hybrid capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens.

Authors:  J Schachter; E W Hook; W M McCormack; T C Quinn; M Chernesky; S Chong; J I Girdner; P B Dixon; L DeMeo; E Williams; A Cullen; A Lorincz
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

Review 2.  Pelvic inflammatory disease.

Authors:  J Ross
Journal:  BMJ       Date:  2001-03-17

3.  A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate.

Authors:  L V Stamm; H L Bergen
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

4.  The communicable disease impact of eliminating publicly funded prenatal care for undocumented immigrants.

Authors:  H Kuiper; G A Richwald; H Rotblatt; S Asch
Journal:  Matern Child Health J       Date:  1999-03

5.  Use of synthetic cardiolipin and lecithin in the antigen used by the venereal disease research laboratory test for serodiagnosis of syphilis.

Authors:  A R Castro; W E Morrill; W A Shaw; D C Gale; M M Park; L A Peregrino-Ferreira; M L Bazzo; V Pope
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

6.  CDC promotes the female condom for HIV/STD prevention.

Authors:  Y Green
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

7.  Evaluation of COBAS AMPLICOR (Roche): accuracy in detection of Chlamydia trachomatis and Neisseria gonorrhoeae by coamplification of endocervical specimens.

Authors:  C H Livengood; J W Wrenn
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

Review 8.  Prevention of HIV among adolescents.

Authors:  M J Rotheram-Borus; Z O'Keefe; R Kracker; H H Foo
Journal:  Prev Sci       Date:  2000-03

Review 9.  Immigrant women's health: Infectious diseases - Part 2.

Authors:  R Avery
Journal:  West J Med       Date:  2001-10

Review 10.  Recent advances: Sexually transmitted infections.

Authors:  R J Gilson; A Mindel
Journal:  BMJ       Date:  2001-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.